




Searching News Database: GAMMAGARD
HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
HSMN NewsFeed - 5 Oct 2009
Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
HSMN NewsFeed - 27 Jul 2009
Halozyme Therapeutics Appoints Jonathan Leff, M.D. as Vice President, Chief Medical Officer
Halozyme Therapeutics Appoints Jonathan Leff, M.D. as Vice President, Chief Medical Officer
HSMN NewsFeed - 16 Mar 2009
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
HSMN NewsFeed - 23 Sep 2008
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
HSMN NewsFeed - 2 Sep 2008
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
HSMN NewsFeed - 13 Nov 2007
Halozyme Therapeutics Names Matthew R. Hooper Vice President, General Counsel
Halozyme Therapeutics Names Matthew R. Hooper Vice President, General Counsel
Additional items found! 3

Members Archive contains
3 additional stories matching:
GAMMAGARD
(Password required)
GAMMAGARD
(Password required)